[MedAware in Health Medicine Netword] Researcher discusses how machine learning helps identify patients at risk level for opioid use disorder

Ronen Rozenblum, Ph.D., MPH, director of the Unit for Innovative Healthcare Practice & Technology and director of Business Development of the Center for Patient Safety Research and Practice at Brigham and Women’s Hospital, and an assistant professor at Harvard Medical School, is the principal investigator and senior author of a new study published in JMIR Medical Informatics, “A Machine Learning Application to Classify Patients at Differing Levels of Risk of Opioid Use Disorder: Clinician Based Validation Study.”

Read more here.